About
Female
Sangeeta N. Bhatia is based out of Massachusetts, United States and is the Co-Founder of Port Therapeutics. Sangeeta previously worked at BioIVT as a Co-Founder. Sangeeta N. Bhatia attended Harvard Medical School.
Experience
Sunbird Bio
View →Co-Founder
Venture43Singapore, Central Region, SingaporeBiotech/Pharma · Biotechnology
- Co-Founder · Amplifyer Bio2023 – present
- Co-Founder · Port Therapeutics2022 – present
- Co-Founder · Satellite Bio2020 – present
- Co-Founder & Chair of Scientific Advisory Board · Glympse Bio2015 – present
- Fellow, Board of Trustees · Brown University2015 – present
- Member of the Board of Directors · Vertex Pharmaceuticals2015 – present
- Professor of Electrical Engineering and Computer Sciences · Massachusetts Institute of Technology2005 – present
- Clinical and Scientific Advisor Board · Alcyone Lifesciences
- Associate Member · Broad Institute
- Member · Harvard Stem Cell Institute
Education
- Massachusetts Institute of Technology · PhD, Biomedical Engineering
- Massachusetts Institute of Technology · MS, Mechanical Engineering
- Harvard Medical School · MD, unknown
- Brown University · ScB, Biomedical Engineering
People at Sunbird Bio
Data from: crunchbase